ProfileJobs

Foundation Medicine

Healthclinical researchlife sciences
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Company Growth (employees)
Type
Public
HQ
Cambridge, US
Founded
2010
Size (employees)
535 (est)+29%
Website
foundationmedicine.com
Foundation Medicine was founded in 2010 and is headquartered in Cambridge, US

Key People at Foundation Medicine

Michael J. Pellini

Michael J. Pellini

President & CEO & Board Director
Steven J. Kafka

Steven J. Kafka

Chief Business Officer
Alexis Borisy

Alexis Borisy

Co - Founder & Chairman of the Board
Vincent A. Miller

Vincent A. Miller

SVP, Clinical Development

Foundation Medicine Office Locations

Foundation Medicine has an office in Cambridge
Cambridge, US (HQ)
150 Second St

Foundation Medicine Data and Metrics

Foundation Medicine Financial Metrics

Foundation Medicine's revenue was reported to be $16.7 m in Q1, 2017
USD

Revenue (Q1, 2017)

16.7 m

Gross profit (Q1, 2017)

(436 k)

Gross profit margin (Q1, 2017), %

(3%)

Net income (Q1, 2017)

(46.5 m)

EBIT (Q1, 2017)

(46.7 m)

Market capitalization (21-Jul-2017)

1.3 b

Cash (31-Mar-2017)

49.1 m
Foundation Medicine's current market capitalization is $1.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

29 m61.1 m93.2 m116.9 m

Revenue growth, %

111%53%25%

Cost of goods sold

11.7 m27.4 m36.7 m53 m

Gross profit

17.3 m33.6 m56.5 m63.9 m

Gross profit Margin, %

60%55%61%55%

R&D expense

67.4 m

General and administrative expense

48.6 m

Operating expense total

59.1 m86.9 m146.3 m230.7 m

EBIT

(41.8 m)(53.3 m)(89.8 m)(113.8 m)

EBIT margin, %

(144%)(87%)(96%)(97%)

Interest expense

235 k42 k124 k624 k

Interest income

624 k

Net Income

(42.9 m)(52.2 m)(89.6 m)(113.2 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

14.5 m16.4 m19.3 m18.3 m21 m17.4 m20.7 m16.3 m16.7 m

Cost of goods sold

6.6 m7.5 m8.9 m9 m9.1 m10 m11.5 m14.7 m17.1 m

Gross profit

7.9 m8.9 m10.4 m9.4 m11.9 m7.4 m9.2 m1.6 m(436 k)

Gross profit Margin, %

54%54%54%51%57%42%45%10%(3%)

R&D expense

8.6 m7.2 m8.7 m10.3 m12.2 m13.5 m18.5 m17.2 m23.3 m

General and administrative expense

5.8 m6.8 m8.8 m23.8 m9.2 m9.2 m12.5 m13 m15.3 m

Operating expense total

14.5 m14 m17.5 m34 m21.4 m22.7 m31 m30.3 m38.6 m

EBIT

(13.8 m)(13 m)(17 m)(33.1 m)(20.6 m)(17.5 m)(29.2 m)(31.4 m)(46.7 m)

EBIT margin, %

(95%)(79%)(88%)(181%)(98%)(100%)(141%)(192%)(280%)

Interest expense

(16 k)(2 k)(29 k)(18 k)(10 k)(57 k)

Interest income

7 k9 k15 k178 k208 k199 k

Net Income

(13.8 m)(13 m)(17 m)(33.1 m)(20.6 m)(17.3 m)(29 m)(31.3 m)(46.5 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

124.3 m72.1 m117.8 m63.6 m

Accounts Receivable

6.3 m9.9 m7.4 m8.2 m

Inventories

992 k2.9 m6.5 m10.4 m

Current Assets

133.3 m89.6 m229.6 m168.9 m

PP&E

22.1 m21 m41.3 m41.5 m

Total Assets

157.3 m111.9 m298 m214 m

Accounts Payable

7 m7.3 m10.5 m11.9 m

Current Liabilities

15.8 m16.4 m29.9 m40.7 m

Additional Paid-in Capital

221.5 m228.2 m489.5 m509.7 m

Retained Earnings

(89.8 m)(142 m)(231.6 m)(344.8 m)

Total Equity

131.7 m86.2 m257.7 m164.8 m

Financial Leverage

1.2 x1.3 x1.2 x1.3 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

97.1 m86.7 m61.7 m263.6 m250.2 m86.1 m62.3 m77.8 m49.1 m

Accounts Receivable

6.1 m6 m10.7 m5.9 m

Inventories

2.6 m4.2 m4.5 m6.1 m9.5 m6.7 m10.2 m12 m10.3 m

Current Assets

106.9 m98.3 m80.8 m289.5 m275.8 m235.9 m216.8 m196.5 m125.5 m

PP&E

21.7 m21.1 m25.1 m31 m36.8 m41.1 m41.2 m42 m39.6 m

Total Assets

130.6 m121.6 m107.9 m322.8 m315 m280.6 m261.6 m242.3 m168.6 m

Accounts Payable

5.5 m5.5 m9.4 m9.4 m12 m8.5 m10.8 m12 m10.4 m

Current Liabilities

12.7 m15.2 m23.4 m22.1 m30.6 m27 m32.7 m39 m34.4 m

Additional Paid-in Capital

223.6 m225.3 m233.8 m481.6 m486.1 m492.7 m497.5 m503.5 m517.7 m

Retained Earnings

(115.7 m)(128.7 m)(159 m)(192 m)(212.6 m)(248.9 m)(277.9 m)(309.2 m)(391.3 m)

Total Equity

107.9 m96.7 m74.8 m289.6 m273.5 m243.7 m219.6 m194.4 m126.3 m

Financial Leverage

1.2 x1.3 x1.4 x1.1 x1.2 x1.2 x1.2 x1.2 x1.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(42.9 m)(52.2 m)(89.6 m)(113.2 m)

Depreciation and Amortization

5 m8.2 m10.6 m15.9 m

Accounts Receivable

(4.1 m)(3.6 m)2.4 m(844 k)

Inventories

(442 k)(1.9 m)(3.7 m)(2.4 m)

Accounts Payable

1.7 m3.1 m(1.6 m)5.1 m

Cash From Operating Activities

(30.8 m)(42.7 m)(63.7 m)(67.2 m)

Purchases of PP&E

(6.9 m)(9.7 m)(25.4 m)(20.9 m)

Cash From Investing Activities

(8.5 m)(8.8 m)(140.7 m)12.7 m

Cash From Financing Activities

108.7 m(650 k)250.1 m333 k

Interest Paid

171 k263 k263 k77 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(13.8 m)(13 m)(17 m)(33.1 m)(20.6 m)(17.3 m)(29 m)(31.3 m)(46.5 m)

Accounts Receivable

6.1 m6 m10.7 m5.9 m

Inventories

2.6 m4.2 m4.5 m6.1 m9.5 m6.7 m10.2 m12 m10.3 m

Accounts Payable

5.5 m5.5 m9.4 m9.4 m12 m8.5 m10.8 m12 m10.4 m
USDY, 2017

Revenue/Employee

31.2 k

Financial Leverage

1.3 x

Foundation Medicine Operating Metrics

Foundation Medicine's Customers was reported to be 30 in FY, 2016. Foundation Medicine's Facilities was reported to be 4 in FY, 2016
FY, 2016

Products

5

Customers

30

Facilities

4

Foundation Medicine Market Value History

Foundation Medicine Revenue Breakdown

Foundation Medicine Median Salaries

Source: 15 public H-1B filings from Foundation Medicine

Market Position of Foundation Medicine

Competitors

Prothena Corporation plc
Health - Public
Creative Medical Technology Holdings
Health - Public
Bio-Techne
Health - Public
Enzo Biochem
Health - Public
Compare competitors

Foundation Medicine Online and Social Media Presence

Foundation Medicine News and Updates

Foundation Medicine Company Life and Culture

You may also be interested in